About

Publications While At HealthPartners

selected publications

Journal Article

Association of cardiovascular outcomes and mortality with sustained long-acting insulin only vs long-acting plus short-acting insulin treatment. 

JAMA network open. 2021

Inequities in hypertension control in the United States exposed and exacerbated by COVID-19 and the role of home blood pressure and virtual health care during and after the COVID-19 pandemic. 

Journal of the American Heart Association. 2021

Comparison of mortality and major cardiovascular events among adults with type 2 diabetes using human vs analogue insulins. 

JAMA network open. 2020

Trends in incidence of hospitalized acute myocardial infarction in the Cardiovascular Research Network (CVRN). 

American Journal of Medicine. 2017

Medication adherence does not explain black-white differences in cardiometabolic risk factor control among insured patients with diabetes. 

Journal of General Internal Medicine. 2016

Prevalence of chronic kidney disease among individuals with diabetes in the SUPREME-DM Project, 2005-2011. 

Journal of Diabetes and Its Complications. 2015

Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, and lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis. 

Diabetes care. 2015

Who must we target now to minimize future cardiovascular events and total mortality? Lessons from the Surveillance, Prevention and Management of Diabetes Mellitus (SUPREME-DM) cohort study. 

Circulation: Cardiovascular Quality and Outcomes. 2015

Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiaries. 

JAMA. 2013

The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research. 

Circulation: Cardiovascular Quality and Outcomes. 2008

Abstract

Impact of human versus analog insulins on occurrence of myocardial infarction [abstract]. 

Diabetologia. 2017

Surveillance of cardiovascular events and total mortality among insured adults with and without diabetes: the SUPREME Cohort Study [abstract 55-OR]. 

Diabetes. 2015

presentations

Presentation

Comparative cardiovascular safety of human versus analog insulins [presentation], EDEG (European Diabetes Epidemiology Group) 2017 Meeting

Impact of human versus analog insulins on mortality and occurrence of myocardial infarction [presentation], Third Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group

Impact of human versus analog insulins on occurrence of myocardial infarction [presentation], CVOT (Cardiovascular Outcome Trial) 3rd Summit of Diabetes and Cardiovascular Disease - EASD Study Group

Contact

full name

K. Reynolds

Quick Info

 

Collaboration

Co-author network

Map of science